News

Orit Markowitz, MD, highlighted takeaways from her SDPA presentation on the recognition of benign patterns in dermoscopy.

Discover how advancements in biologic therapies and precision medicine are transforming asthma and COPD management, enhancing patient care and outcomes.

A recent post hoc analysis of 2 pivotal phase 3 trials has determined the efficacy of acoltremon .003% in reducing ocular surface damage in dry eye disease.

From uncovering new benefits of semaglutide to targeting hypercortisolism in people with type 2 diabetes, here are 5 key updates from the annual meeting.

Chang reviews key points from her recent paper on the evolving landscape of eosinophilic esophagitis management and lingering knowledge gaps.

Jennifer Lai, MD, shares science-backed strategies for clinicians to counsel patients on nutrition and liver health.

This case study underscores how fragmented care and weight bias can contribute to late-stage MASH diagnosis.

A patient’s near-fatal journey from undiagnosed fatty liver disease to liver transplant highlights the urgent need for better screening and stigma-free communication.

This interview at SDPA features Janelle Ball, founder and CEO of BC Educators, who discusses tips related to success with insurance authorizations.

Amlitelimab shows promise as a safe and effective treatment for moderate-to-severe atopic dermatitis, with sustained benefits post-treatment.

This interview segment at the 2025 SDPA Conference highlights additional insights by Friedman on the management and diagnosis of chronic hand eczema, or CHE.

Based on recent data, artificial intelligence can improve patients’ awareness of their condition, as well as confidence in, and satisfaction with, their care.

In an interview conducted at the 2025 SDPA Conference, Friedman provided several insights into management and diagnosis of chronic hand eczema, or CHE.

At SDPA 2025, Candrice Heath, MD, said many clinicians remain unaware of baby perfume traditions that may contribute to persistent symptoms in patients of color.

The analysis of Rome Foundation Global Epidemiology Study data identified 4 dietary pattern clusters linked to variations in the global prevalence and severity of IBS.

Research has indicated a substantial increase in axial length, a contributing factor of myopia, in young adults who report regular mobile device usage.

At SDPA 2025, Candrice Heath, MD, presented on what you can do in your clinic to bridge the gap in pediatric atopic dermatitis among children with darker skin tones.

This session with Ginette Okoye, MD, features a discussion about hidradenitis suppurativa (HS) and several helpful approaches for patients.

Verma discussed how recent advances in the field affect clinician management of type 2 diabetes and peripheral artery disease.

Positive topline results show the trial met its primary endpoint for MASH resolution and fibrosis improvement, with significant weight loss effects without plateauing.

Dellon describes what excites him most about EoE recently but points to barriers to optimal care as well as unanswered research questions and clinical needs.

Despite its availability as an over-the-counter medication, BTOS is frequently prescribed by clinicians for the treatment of ocular redness due to minor eye irritations.

Verma discussed how new data from the STRIDE trial support the role of GLP-1 RAs as protective vascular medications.

Donovan and Feig shared exciting findings and further research from a study evaluating an insulin pump with Control-IQ technology with Dexcom G6 sensor.

This interim report of an ongoing study has indicated an overall positive impression of the INFUSE for Astigmatism contact lens among a 100-patient population.

Check out the top 5 interviews from SLEEP 2025.

A survey study has indicated a substantially positive perspective on UMFfA contact lenses, including reports on well-maintained vision, comfort, and ease of fitting.